Choosing the proper study design can lead to shorter timelines, increase cost effectiveness, and can improve the chances of successful outcomes. The right design can make the difference between a successful company and a failed venture.

Bayesian and group sequential statistical designs can put businesses at ease by allowing interim analysis of the study to help make stop/go decisions for the trial. The risk of choosing the wrong control group or treatment can be minimized through adaptive designs.

Symbios Clinical provides statistical services to suit your needs, including support for clinical strategy or IP design, statistical analysis and final report authoring.

View our LifeScience Alley presentation on adaptive designs using statistical and operational considerations in planning and conducting an adaptive trial.